SCHEMBL368406

SCHEMBL368406

CN(C)c1ccc(C(C/C(=N/O)c2ccncc2)c2c[nH]c3ccccc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.69
KMT2A Q03164 9/20 0.58
L3MBTL1 Q9Y468 9/20 0.58
MAPT P10636 8/20 0.58
MEN1 O00255 8/20 0.58
ALDH1A1 P00352 7/20 0.58
TDP1 Q9NUW8 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
USP2 O75604 1/20 0.58
MAPK1 P28482 3/20 0.55
MCL1 Q07820 3/20 0.51
LMNA P02545 2/20 0.51
GAA P10253 9/20 0.48
MGAM O43451 8/20 0.47
SI P14410 8/20 0.47
MGAM2 Q2M2H8 8/20 0.47
FFAR1 O14842 1/20 0.42
GPR84 Q9NQS5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368407 1.00 GPBAR1 (0.69) GPBAR1KMT2AL3MBTL1MAPTMEN1
SCHEMBL10280819 1.00 GPBAR1 (0.69) GPBAR1KMT2AL3MBTL1MAPTMEN1
SCHEMBL368646 0.86 GAA (0.66) KMT2AL3MBTL1MAPTMEN1ALDH1A1
SCHEMBL364632 0.83 GPBAR1 (1.00) GPBAR1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL10240825 0.83 GPBAR1 (1.00) GPBAR1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL10240827 0.83 GPBAR1 (1.00) GPBAR1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL364631 0.83 GPBAR1 (1.00) GPBAR1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL364630 0.83 GPBAR1 (1.00) GPBAR1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL1389944 0.82 GPBAR1 (0.80) GPBAR1KMT2AL3MBTL1MAPTMEN1
SCHEMBL1389941 0.82 GPBAR1 (0.80) GPBAR1KMT2AL3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP claimed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885KMT2A 3981/4885L3MBTL1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.